Evolus Inc. (EOLS) is priced at $12.29 after the most recent trading session. At the very opening of the session, the stock price was $10.61 and reached a high price of $14.81, prior to closing the session it reached the value of $7.16. The stock touched a low price of $9.55.
Recently in News on February 19, 2021, Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference. Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Evolus Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $14.81 on 02/19/21, with the lowest value was $3.06 for the same time period, recorded on 01/05/21.
Evolus Inc. (EOLS) full year performance was 17.38%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Evolus Inc. shares are logging 15.62% during the 52-week period from high price, and 331.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.85 and $10.63.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 33762520 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Evolus Inc. (EOLS) recorded performance in the market was 265.77%, having the revenues showcasing 238.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 241.62M, as it employees total of 125 workers.
The Analysts eye on Evolus Inc. (EOLS)
During the last month, 6 analysts gave the Evolus Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.59, with a change in the price was noted +8.43. In a similar fashion, Evolus Inc. posted a movement of +218.39% for the period of last 100 days, recording 1,010,011 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for EOLS is recording 3.79 at the time of this writing. In addition, long term Debt to Equity ratio is set at 3.79.
Technical rundown of Evolus Inc. (EOLS)
Raw Stochastic average of Evolus Inc. in the period of last 50 days is set at 78.55%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 72.49%. In the last 20 days, the company’s Stochastic %K was 54.50% and its Stochastic %D was recorded 52.11%.
Considering, the past performance of Evolus Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 265.77%. Additionally, trading for the stock in the period of the last six months notably improved by 216.75%, alongside a boost of 17.38% for the period of the last 12 months. The shares increased approximately by 74.57% in the 7-day charts and went down by 112.26% in the period of the last 30 days. Common stock shares were driven by 238.57% during last recorded quarter.